Approval · Notice of Compliance 8211 · 2006
AZILECT: Notice of Compliance 8211
Issued August 17, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8211
- Date
- August 17, 2006
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antiparkinson agent
Products in this notice
Medicinal ingredients
- RASAGILINE MESYLATE 0.5 MG per TAB
- RASAGILINE MESYLATE 1 MG per TAB